- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers ; volume:4 ; number:2 ; day:17 ; month:6 ; year:2009 ; pages:1 ; date:6.2009
Infectious agents and cancer ; 4, Heft 2 (17.6.2009), 1, 6.2009
- Urheber
-
Bhatt, A.
- Beteiligte Personen und Organisationen
-
Bhende, P.
Damania, B.
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-4-S2-O7
- URN
-
urn:nbn:de:1111-2016072622758
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bhatt, A.
- Bhende, P.
- Damania, B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
Nascent proteome analysis of MAPK and PI3K-AKT-mTOR oncogenic signaling pathways
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
Nascent proteome analysis of MAPK and PI3K-AKT-mTOR oncogenic signaling pathways
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade